deltatrials
Not Yet Recruiting OBSERVATIONAL NCT03569553

A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients

A Field Study for the Evaluation of AIGIV Clinical Benefit and Safety in the Treatment of Patients With Inhalational Anthrax in a Broad Exposure Event Scenario

Sponsor: Centers for Disease Control and Prevention

Conditions Inhalational Anthrax
Interventions AIGIV
Updated 16 times since 2018 Last updated: Feb 4, 2026 Started: May 30, 2027 Primary completion: Jul 31, 2027 Completion: Jul 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Inhalational Anthrax and is currently actively recruiting participants. Centers for Disease Control and Prevention leads this study, which shows 16 recorded versions since 2027 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jul 2018 – ~Sep 2018 · 2 months · monthly snapshot~Sep 2018 – ~Feb 2019 · 5 months · monthly snapshot~Feb 2019 – ~May 2020 · 15 months · monthly snapshot~May 2020 – ~Oct 2020 · 5 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Sep 2022 · 9 months · monthly snapshot~Sep 2022 – ~Apr 2023 · 7 months · monthly snapshot~Apr 2023 – ~Oct 2023 · 6 months · monthly snapshot~Oct 2023 – ~Mar 2024 · 5 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~Sep 2025 · 7 months · monthly snapshot~Sep 2025 – ~Feb 2026 · 5 months · monthly snapshot~Feb 2026 – present · 5 months · monthly snapshot

Change History

16 versions recorded

  1. Feb 2026 — Present [monthly]

    Not Yet Recruiting

  2. Sep 2025 — Feb 2026 [monthly]

    Not Yet Recruiting

  3. Feb 2025 — Sep 2025 [monthly]

    Not Yet Recruiting

  4. Sep 2024 — Feb 2025 [monthly]

    Not Yet Recruiting

  5. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting

▶ Show 11 earlier versions

  1. Mar 2024 — Jul 2024 [monthly]

    Not Yet Recruiting

  2. Oct 2023 — Mar 2024 [monthly]

    Not Yet Recruiting

  3. Apr 2023 — Oct 2023 [monthly]

    Not Yet Recruiting

  4. Sep 2022 — Apr 2023 [monthly]

    Not Yet Recruiting

  5. Dec 2021 — Sep 2022 [monthly]

    Not Yet Recruiting

  6. Jan 2021 — Dec 2021 [monthly]

    Not Yet Recruiting

  7. Oct 2020 — Jan 2021 [monthly]

    Not Yet Recruiting

  8. May 2020 — Oct 2020 [monthly]

    Not Yet Recruiting

  9. Feb 2019 — May 2020 [monthly]

    Not Yet Recruiting

  10. Sep 2018 — Feb 2019 [monthly]

    Not Yet Recruiting

  11. Jul 2018 — Sep 2018 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centers for Disease Control and Prevention
  • Department of Health and Human Services
  • Emergent BioSolutions
Data source: Emergent BioSolutions

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.